Affidea Group, the leading European provider of diagnostic imaging, outpatient and cancer care services has today announced the acquisition of Orthoderm, a highly regarded outpatient healthcare provider with a reputation for the delivery of innovative and quality care from its clinic located outside Belfast in Northern Ireland. With this acquisition, Affidea builds further on its strategic vision to broaden its business model and add new outpatient care services that can complement its portfolio in patient centric care delivery.
Founded in 2007, Orthoderm prides itself as being a leading provider of clinical and medical services across a wide range of medical and surgical specialties including Dermatology, Plastic surgery and Orthopaedics as well as pain management and GP services. Located on site are two local anaesthetic theatres for day surgeries which makes the clinic very attractive for patients, insurers and trusts. In addition to the aforementioned range of services, Orthoderm provides physiotherapy and rehabilitation services through the Room One Physiotherapy practice. Room One enjoys an enviable reputation in the market as being the preferred provider for the sports community in Northern Ireland. Orthoderm remains on the Health & Social Care Board Select List for various specialties and continues to provide support to the Trusts through various waiting list initiatives.
Giuseppe Recchi, Affidea Group CEO, said: “Orthoderm, with its first class facility and strong reputation for medical excellence, represents an ideal addition to the Affidea portfolio and we are delighted to have them join our European network. We have started the year with a strong appetite for expansion. The two major acquisitions announced this week, Fortius and Orthoderm, are a proof that we are moving full speed and in line with our strategy to consolidate Affidea’s position in markets with strong potential for continued growth, while, at the same time, expanding our portfolio of outpatient capabilities”.
Commenting on the acquisition, Michael and Elizabeth Eames, co-directors of Orthoderm, are delighted to be joining the Affidea Group - “Orthoderm prides itself in providing a high standard of timely and efficient patient care in Northern Ireland across a wide range of medical and surgical specialties. Our team is highly motivated and we look forward to the opportunity to work with Affidea to expand the range of services that we offer to our patients”.
Barry Downes, Country Manager for Affidea Ireland, mentioned: "With each acquisition we look for synergies that can add value to our patients ensuring the continued provision of excellence in medical care. Adding Orthoderm to our network will result in best-in-class access to a wide rage of medical services which will enable us to serve our patients, doctors and health systems across Northern and Southern Ireland on a much more integrated level. We look forward to working with the Orthoderm team during what is a very innovative period for healthcare to further develop and enhance our patient offering.
Orthoderm is the fourth acquisition of Affidea in the last three months after Fortius clinic, the renowned UK healthcare provider in sports medicine, announced this week, Sveti Rok, a reputed healthcare provider in Zagreb, Croatia, announced at the beginning of December 2020 and Clinica Gamma, a nuclear medicine operator in Madrid announced in January 2021. Affidea has a long-term track record in successfully adding and integrating more than 140 centers in the last 5 years, reaching 280 centers across 15 countries in Europe, with over 8,500 professionals serving more than 7 million patients every year.
Deloitte Northern Ireland assisted Affidea in relation to the acquisition as their Finance and Tax Advisors, while Flynn O'Driscoll acted as Legal Advisor. HNH was the Financial and Tax Advisors for Orthoderm while A&L Goodbody assisted them as Legal advisor.
